Revance Therapeutics Inc

Provides critical analysis and revenue estimates for tax legislation, directly influencing corporate tax structures and the overall tax burden on industries like pharmaceutical manufacturing.

Controls taxation, trade, and entitlement spending (e.g., Medicare pricing). Both tax policy and Medicare reimbursement rates directly and substantially impact a pharmaceutical company's profitability and market access.

Allocates federal spending, including budgets for agencies like the FDA and NIH, which directly regulate and fund research relevant to pharmaceutical companies, significantly impacting their operating environment.

Regulates the FDA and NIH. Drug approval oversight is existential for a pharmaceutical company, making this committee a direct and primary regulatory influencer.

Oversees antitrust laws and, crucially, intellectual property (patents), which are fundamental to the pharmaceutical industry's business model and competitive landscape.

Investigates issues like drug pricing and long-term care quality. Drug pricing is a critical determinant of revenue and profitability for pharmaceutical companies like Revance Therapeutics.